Santa Cruz Biotechnology now offers a broad range of alpha2C-AR Activators. There are five general types of adrenergic receptors (ARs), designated α1, α2, β1, β2 and β3, which are found in different target tissues and differ in their affinities and responses to various agonists and antagonists. alpha2C-AR Activators offered by Santa Cruz activate alpha2C-AR and, in some cases, other G protein-coupled receptor kinases (GRKs) and PKC-directed phosphorylation related proteins. View detailed alpha2C-AR Activator specifications, including alpha2C-AR Activator CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
indicates a highly recommended product based on customer preference.
PRODUCT NAME/Application | CAS | Catalog # | QUANTITY | Price | Citations | RATING | |
---|---|---|---|---|---|---|---|
Xylazine HydrochlorideXylazine Hydrochloride is an adrenergic alpha-2 agonist |
23076-35-9 |
sc-220393 |
1 g |
$50.00
|
1 |
| |
Guanabenz acetateGuanabenz acetate is an α2A-AR agonist and IGRS selective ligand |
23256-50-0 |
sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D |
100 mg 500 mg 1 g 10 g 25 g |
$98.00
$450.00 $800.00 $4,000.00 $7,000.00 |
2 |
| |
ST 91ST 91 is an α2-adrenoceptor agonist |
4749-61-5 |
sc-203703 sc-203703A |
10 mg 50 mg |
$129.00
$548.00 |
0 |
| |
Medetomidine hydrochlorideMedetomidine hydrochloride is a potent and highly selective α2-adrenoceptor agonist used as an anesthetic and analgesic. |
86347-15-1 |
sc-204073 sc-204073A |
10 mg 50 mg |
$119.00
$475.00 |
2 |
| |
Xylometazoline hydrochlorideXylometazoline hydrochloride is α-adrenoceptor agonist |
1218-35-5 |
sc-255719 |
5 g |
$164.00
|
0 |
| |
(R)-(+)-m-Nitrobiphenyline oxalate(R)-(+)-m-Nitrobiphenyline oxalate is an α2C-AR agonist which inhibits cAMP accumulation |
945618-97-3 |
sc-204226 sc-204226A |
10 mg 50 mg |
$200.00
$739.00 |
0 |
| |
p-Iodoclonidine hydrochloridep-Iodoclonidine hydrochloride is A high affinity α2 adrenergic receptor agonist |
108294-53-7 |
sc-257955 |
25 mg |
$45.00
|
0 |
|